NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 317 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,673,038 | +22.7% | 43,153 | +3.6% | 0.02% | +20.0% |
| Q1 2024 | $3,808,852 | +35.2% | 41,645 | -7.4% | 0.02% | +36.4% |
| Q4 2023 | $2,817,798 | +51.0% | 44,984 | +6.7% | 0.01% | +37.5% |
| Q3 2023 | $1,866,000 | -18.1% | 42,169 | -10.0% | 0.01% | -11.1% |
| Q2 2023 | $2,279,000 | -15.5% | 46,841 | -3.5% | 0.01% | -18.2% |
| Q1 2023 | $2,696,000 | +34.1% | 48,559 | -3.0% | 0.01% | +22.2% |
| Q4 2022 | $2,011,000 | +6.0% | 50,066 | +15.6% | 0.01% | 0.0% |
| Q3 2022 | $1,897,000 | +24.6% | 43,299 | +0.8% | 0.01% | +50.0% |
| Q2 2022 | $1,522,000 | -13.7% | 42,958 | -0.9% | 0.01% | 0.0% |
| Q1 2022 | $1,764,000 | -57.9% | 43,369 | -3.4% | 0.01% | -57.1% |
| Q4 2021 | $4,192,000 | -19.3% | 44,889 | -3.6% | 0.01% | -22.2% |
| Q3 2021 | $5,192,000 | +2.4% | 46,587 | +4.3% | 0.02% | 0.0% |
| Q2 2021 | $5,071,000 | +3214.4% | 44,669 | +2870.0% | 0.02% | +1700.0% |
| Q1 2021 | $153,000 | – | 1,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |